首页 / 院系成果 / 成果详情页

Complete hematological response with imatinib mesylate in a corticosteroid refractory idiopathic hypereosinophilic syndrome in person living with HIV: A case report 期刊论文

编号：

3FB7259FDE8557C9D519D24766BDD64F
作者：

Lubis, Anna Mira^[1] Yunihastuti, Evy^[2,3] Harahap, Agnes Stephanie^[4] Anindyah, Gabriella^[5] Yasmin, Amirah^[5] Aisyah, Matdoan Rifkiah^[6]
语种：

英文
期刊：

INTERNATIONAL JOURNAL OF STD & AIDS ISSN：0956-4624 2025 年 ; 2025 MAY 7
疾病分类：

艾滋病
关键词：

Human immunodeficiency virus (HIV) hypereosinophilic syndrome (HES) imatinib
摘要：

We present a case of a 38-year-old person living with HIV (PLHIV) diagnosed with refractory idiopathic hypereosinophilic syndrome (HES). His initial symptoms were pruritic skin rash, dry cough, and diarrhea. The patient was unresponsive to corticosteroid as a first-line therapy. Subsequent treatment with Imatinib mesylate 100 mg per day resulted in excellent and sustained hematological and clinical response, with a likely molecular response as well.
推荐引用方式
GB/T 7714：

Lubis Anna Mira,Yunihastuti Evy,Harahap Agnes Stephanie, et al. Complete hematological response with imatinib mesylate in a corticosteroid refractory idiopathic hypereosinophilic syndrome in person living with HIV: A case report [J].INTERNATIONAL JOURNAL OF STD & AIDS,2025.
APA：

Lubis Anna Mira,Yunihastuti Evy,Harahap Agnes Stephanie,Anindyah Gabriella,&Aisyah Matdoan Rifkiah.(2025).Complete hematological response with imatinib mesylate in a corticosteroid refractory idiopathic hypereosinophilic syndrome in person living with HIV: A case report .INTERNATIONAL JOURNAL OF STD & AIDS.
MLA：

Lubis Anna Mira, et al. "Complete hematological response with imatinib mesylate in a corticosteroid refractory idiopathic hypereosinophilic syndrome in person living with HIV: A case report" .INTERNATIONAL JOURNAL OF STD & AIDS(2025).
数据来源自科睿唯安Web of Science核心合集
入库时间：

2025/5/14 11:58:23
更新时间：

2025/5/14 11:58:23

浏览次数：4  下载次数：0

分享到：

浏览次数：4

下载次数：0

打印次数：0